Navigation Links
Nobel Laureate Lee Hartwell to Retire as President and Director of Fred Hutchinson Cancer Research Center in 2010
Date:6/26/2009

SEATTLE, June 26 /PRNewswire/ -- The Fred Hutchinson Cancer Research Center board of trustees today announced that its president and director, Lee Hartwell, Ph.D., plans to retire in June 2010. Hartwell, a recipient of the 2001 Nobel Prize in physiology or medicine, has been president and director of the Hutchinson Center since 1997.

"It's time," Hartwell said. "I have been president and director of the Center for 12 years. It's time for new leadership." Hartwell, who will turn 70 in October, says he informed the board's executive committee more than a year ago of his desire to retire and to begin the transition to new leadership. The exact timing of his departure was worked out over the last few months. The full board, faculty and staff were notified during the past two days.

Today's announcement was made by Doug Walker, chair of the Center's board of trustees, who said the search for Hartwell's successor will begin immediately. "Lee's leadership over these last 12 years has been extraordinary," Walker said. "It's hard for us to picture Fred Hutchinson Cancer Research Center without Lee at the helm. We're fortunate that Lee will be around to ensure that the transition to new leadership will be an extremely smooth one."

Walker says a search committee has been selected and it, in turn, will select a consultant to assist with the search. Board member Steve Davis, a senior adviser at McKinsey & Company, will head the search committee, which will also include members of the board and scientific faculty.

"The first thing we need to do is make a thorough assessment of the position and discuss the qualifications for the next Center leader with the Center's scientific faculty as well as community leadership," Walker said. "We'll use this information to determine the qualities and qualifications of the person we hope to recruit. Walker says there is no specific time frame attached to the search. "It will conclude when we have the best candidate for the position," he said.

After Hartwell retires in 2010, he hardly will be idle. He will continue to be involved with the Center as director emeritus and also will continue his work in early cancer detection and science education. He will also continue his role as chairman of the executive committee of the Partnership for Personalized Medicine, an Arizona-based global effort to improve patient outcomes and reduce health care costs.

At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, please visit fhcrc.org.

    CONTACT:
    Kristen Woodward
    206-667-5095
    kwoodwar@fhcrc.org


'/>"/>
SOURCE Fred Hutchinson Cancer Research Center
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Nobel Laureates to Speak at Keystone Symposia RNA Silencing Conference
2. AstraZeneca Nobel Medicine Initiative to Increase Interest in the Nobel Prize in Physiology or Medicine
3. Clontech Laboratories, Inc. Recognizes the 2008 Winners of the Nobel Prize in Chemistry
4. SENOMYX CO-FOUNDER AND SCIENTIFIC ADVISORY BOARD MEMBER ROGER TSIEN, PH.D., AWARDED NOBEL PRIZE IN CHEMISTRY
5. Graphene pioneers follow in Nobel footsteps
6. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
7. Nobel Award in Medicine Holds Strong Messsage for Animal Activists
8. US Oncology Named 2009 Laureate by IDG Computerworld Honors Program
9. Laureate Pharma Honored as Emerging Life Sciences Company of the Year
10. Laureate Pharma Announces Agreement with Tolera Therapeutics, Inc.
11. Laureate Announces Manufacturing Agreement with Tolerx
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche ... with peritoneal or pleural mesothelioma. Their findings are the subject of a new article ... Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... to announce the launch of their brand, UP4™ Probiotics, into Target stores nationwide. ... years, is proud to add Target to its list of well-respected retailers. This ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
Breaking Biology Technology:
(Date:6/22/2016)... On Monday, the Department of Homeland Security (DHS) issued ... the Biometric Exit Program. The Request for Information (RFI), ... that CBP intends to add biometrics to confirm when ... , in order to deter visa overstays, to ... Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
(Date:6/15/2016)... , June 15, 2016 ... market report titled "Gesture Recognition Market by Application Market - Global ... 2016 - 2024". According to the report, the  global ... billion in 2015 and is estimated to grow ... 48.56 billion by 2024.  Increasing application ...
(Date:6/3/2016)... Das DOTM (Department ... hat ein 44 Millionen $-Projekt ... einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an Decatur ... Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale Anbieter ... aber Decatur wurde als konformste und innovativste ...
Breaking Biology News(10 mins):